Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Equity Income (2024 - 2025)

Historic Equity Income for PAVmed (PAVM) over the last 2 years, with Q3 2025 value amounting to -$4.4 million.

  • PAVmed's Equity Income changed N/A to -$4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year change of. This contributed to the annual value of $532000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, PAVmed's Equity Income is -$4.4 million.
  • In the past 5 years, PAVmed's Equity Income registered a high of $21.0 million during Q1 2025, and its lowest value of -$10.6 million during Q2 2025.